<DOC>
	<DOCNO>NCT00612768</DOCNO>
	<brief_summary>An open , prospective , multi-center study evaluate bioequivalence polyvinylpyrrolidone formulation T.R.U.E . TEST fragrance mix thimerosal allergen .</brief_summary>
	<brief_title>Clinical Evaluation T.R.U.E . TESTÂ® Fragrance Mix Thimerosal Allergens : Bioequivalence PVP Formulations</brief_title>
	<detailed_description>We conduct open , prospective , multi-center study evaluate bioequivalence polyvinylpyrrolidone formulation T.R.U.E . TEST fragrance mix thimerosal allergen . Bioequivalence determine 40 adult subject , 20 per allergen , clinical history contact dermatitis positive patch test ( current previous ) correspond reference petrolatum allergen ( `` sensitive '' ) .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Contact</mesh_term>
	<criteria>Current previous symptom and/or history consistent allergic contact dermatitis , positive patch test ( within past 5 year ) fragrance mix AND/OR thimerosal . All subject must adults ( 18 year age old ) otherwise good health . Premenopausal female subject must consent urine pregnancy test ; result must negative study inclusion . Informed consent must sign understood subject , consistent institutional , local national regulation . Subjects unable meet inclusion requirement . Women breastfeed pregnant . Topical treatment last 7 day corticosteroid immunosuppressive agent near test area . Systemic treatment last 7 day corticosteroid ( equivalent &gt; 10 mg prednisone ) immunosuppressive agent . Treatment ultraviolet ( UV ) light ( include tan ) previous 3 week . Acute dermatitis outbreak dermatitis near test area back . Subjects unable comply patch test study requirement include multiple return visit activity restriction ( e.g. , protect test panel excess moisture due shower vigorous activity ) . Subject participation clinical trial investigational drug , treatment , device , T.R.U.E . TEST , study 3 week prior inclusion study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Thimerosal</keyword>
	<keyword>Fragrance Mix</keyword>
	<keyword>PVP formulation</keyword>
	<keyword>Contact dermatitis</keyword>
</DOC>